Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Evaluation of a quantitative double ELISA strategy for confirmation and differentiation of HIV infection.

Rehle TM, Mattke P, Liomba GN, Krämer S, Gershy-Damet GM, Konan K, Sangare A, Zekeng L, Tsague JM, Kaptue L, Eberle J, Gürtler L.

J Virol Methods. 1997 Jul;66(2):203-9.

PMID:
9255731
2.

HIV-1 subtype O: epidemiology, pathogenesis, diagnosis, and perspectives of the evolution of HIV.

Gürtler LG, Zekeng L, Tsague JM, van Brunn A, Afane Ze E, Eberle J, Kaptue L.

Arch Virol Suppl. 1996;11:195-202. Review.

PMID:
8800800
3.

HTLV type I isolated from a Pygmy in Cameroon is related to but distinct from the known central African type.

Chen J, Zekeng L, Yamashita M, Takehisa J, Miura T, Ido E, Mboudjeka I, Tsague JM, Hayami M, Kaptue L.

AIDS Res Hum Retroviruses. 1995 Dec;11(12):1529-31. No abstract available.

PMID:
8679297
4.

Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots.

Gürtler LG, Zekeng L, Simon F, Eberle J, Tsague JM, Kaptue L, Brust S, Knapp S.

J Virol Methods. 1995 Feb;51(2-3):177-83.

PMID:
7537751
5.

Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections.

Schable C, Zekeng L, Pau CP, Hu D, Kaptue L, Gurtler L, Dondero T, Tsague JM, Schochetman G, Jaffe H, et al.

Lancet. 1994 Nov 12;344(8933):1333-4.

PMID:
7968029
6.

A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.

Gürtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, Tsague JM, Kaptue L.

J Virol. 1994 Mar;68(3):1581-5.

Supplemental Content

Loading ...
Support Center